These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 1300272)

  • 21. [The effect of lymphocytapheresis on multiple sclerosis].
    Munakata R; Utsugisawa K; Nagane Y; Ukitsu M; Tohgi H
    No To Shinkei; 1999 Mar; 51(3):235-9. PubMed ID: 10226287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
    Furukawa K; Mori M; Ohta N; Ikeda H; Shida H; Furukawa K; Shiku H
    J Clin Invest; 1994 Nov; 94(5):1830-9. PubMed ID: 7962528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
    Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
    Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enhanced adherence of endothelial cells to blood mononuclear cells in HAM/TSP].
    Cabre P; al-Fahim A; Oger J
    Rev Neurol (Paris); 1999 Apr; 155(4):273-9. PubMed ID: 10367324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human T-lymphotropic virus type I associated myelopathy treated effectively with lymphocytapheresis using a leukocyte removal filter.
    Oishi M; Mochizuki Y; Hara M; Uryu H; Osaka S; Maejima M; Sawada S; Takasu T
    Intern Med; 1995 Dec; 34(12):1215-9. PubMed ID: 8929654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy for HAM/TSP and AIDS].
    Nakagawa M; Maruyama Y; Osame M
    Nihon Rinsho; 1994 Nov; 52(11):3019-25. PubMed ID: 7996704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocytapheresis in combination with immunosuppressive drugs for refractory myasthenia gravis: two-color flow cytometric analysis of changes in peripheral blood lymphocyte subsets.
    Furutama D; Nakajima H; Shinoda K; Makino S; Ohsawa N
    Eur Neurol; 1995; 35(5):270-5. PubMed ID: 8542915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of adherent T cells to human endothelial cells in patients with HTLV-I-associated myelopathy.
    Ichinose K; Nakamura T; Nishiura Y; Nagasato K; Ohishi K; Watanabe H; Fujita A; Kurouji K; Tsujihata M; Nagataki S
    J Neurol Sci; 1994 Apr; 122(2):204-9. PubMed ID: 8021704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of multiple sclerosis with lymphocytapheresis using a leukocyte adsorption column].
    Sato T; Imamura N; Nozaki K; Ishigaki Y
    Nihon Rinsho; 1994 Nov; 52(11):3032-7. PubMed ID: 7996706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a filtration lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis.
    Kondoh T; Hidaka Y; Katoh H; Inoue N; Saito S
    Artif Organs; 1991 Jun; 15(3):180-8. PubMed ID: 1867528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of lymphocytapheresis in a patient with ankylosing spondylitis.
    Ueo T; Kobori K; Okumura H; Ito K; Yoshida H; Norioka M; Shimizu K; Yamamuro T
    Transfus Sci; 1990; 11(1):97-101. PubMed ID: 10149524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial.
    Izumo S; Goto I; Itoyama Y; Okajima T; Watanabe S; Kuroda Y; Araki S; Mori M; Nagataki S; Matsukura S; Akamine T; Nakagawa M; Yamamoto I; Osame M
    Neurology; 1996 Apr; 46(4):1016-21. PubMed ID: 8780082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmapheresis to treat human T lymphotropic virus type I-associated myelopathy.
    Matsuo H; Nakamura T; Shibayama K; Motomura M; Nagasato K; Takeo G; Tsujihata M; Nagataki S
    Curr Stud Hematol Blood Transfus; 1990; (57):198-207. PubMed ID: 2272201
    [No Abstract]   [Full Text] [Related]  

  • 34. [Physiopathology and treatment of HAM].
    Osame M; Usuku K; Umehara F; Saito M; Furukawa Y; Kubota R; Nagai M; Higuchi I; Nakagawa M; Arimura K; Izumo S
    Nihon Naika Gakkai Zasshi; 2003 Sep; 92(9):1673-82. PubMed ID: 14560601
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of lymphocyte depletion and clinical effectiveness on filtration leukocytapheresis in patients with rheumatoid arthritis.
    Ueki Y; Nakamura H; Kanamoto Y; Miyazaki M; Yano M; Matsumoto K; Miyake S; Tominaga T; Tominaga M; Yamasaki S; Eguchi K
    Ther Apher; 2001 Dec; 5(6):455-61. PubMed ID: 11800080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluctuations in the peripheral blood leukocyte and platelet counts in leukocytapheresis in healthy volunteers.
    Yamaji K; Yang K; Tsuda H; Hashimoto H
    Ther Apher; 2002 Dec; 6(6):402-12. PubMed ID: 12460402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic effect of lymphocytapheresis on patients with HTLV-I-associated myelopathy (HAM)].
    Kubota R; Nakagawa M; Nakamura A; Osame M
    Rinsho Shinkeigaku; 1992 Sep; 32(9):984-8. PubMed ID: 1300272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood mononuclear cells in patients with HTLV-I-associated myelopathy: lymphocytes are highly activated and adhesion to endothelial cells is increased.
    Al-Fahim A; Cabre P; Kastrukoff L; Dorovini-Zis K; Oger J
    Cell Immunol; 1999 Nov; 198(1):1-10. PubMed ID: 10612646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
    Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
    J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathogenesis of pulmonary involvement in HTLV-I-associated myelopathy (HAM): studies on T-cell function].
    Sugimoto M; Matsumoto M; Nakashima H; Imamura F; Kawano O; Imamura S; Fukuda Y; Ando M; Araki S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Oct; 27(10):1198-203. PubMed ID: 2615072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.